octopamine has been researched along with Disease Exacerbation in 1 studies
Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Andrea, G | 1 |
| Nordera, G | 1 |
| Pizzolato, G | 1 |
| Bolner, A | 1 |
| Colavito, D | 1 |
| Flaibani, R | 1 |
| Leon, A | 1 |
1 other study available for octopamine and Disease Exacerbation
| Article | Year |
|---|---|
Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages.
Topics: Aged; Amines; Biomarkers; Disease Progression; Female; Humans; Male; Middle Aged; Norepinephrine; Oc | 2010 |